Developer docs
API playgroundTry for free, no card

Search company profiles

Next Dimension (NeD)

Full company profile

uuid002lbnb

Namestring
Next Dimension (NeD)
Legal namestring
Afterio Ltd. (אפטריו בעמ)
Websiteurl
ohv.co.il
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Next Dimension (NeD) is a privately held Israeli medical device company developing Retinal Spectral Imaging Systems intended for the early diagnosis of vision-threatening diseases. The company's core product is a spectral imaging device designed to capture multi-wavelength retinal data to enable earlier detection of ocular pathology compared to conventional fundus imaging. The intended end users are eye care professionals such as ophthalmologists and optometrists operating in clinical settings where early detection of retinal disease drives better patient outcomes.

Founded in 2005 and headquartered in Ofakim, Israel, the company operates with a small team of 1–10 employees as a private for-profit entity. The company is listed as a portfolio company of OHV Ventures, an Israeli venture capital firm, based on the website URL pattern (ohv.co.il/asp/portfolio_company.asp?id=123), indicating institutional backing, though no funding rounds, amounts, or investor details are disclosed in the source material. The company has no publicly disclosed revenue, named customers, distribution partnerships, or pricing model, and no management team composition is available in the source data.

The supporting source material provided is largely about an unrelated Israeli moving services business (MoversTLV / Afterio Ltd.), indicating a data sourcing error. The analysis below is grounded in the firmographic definition provided and is necessarily limited in its conclusions due to the absence of substantive company-specific data such as funding history, clinical validation milestones, regulatory clearances (FDA/CE), customer references, or commercialization metrics.

Short descriptiontext

Next Dimension (NeD) is an Israeli medical device company developing Retinal Spectral Imaging Systems for early diagnosis of vision-threatening diseases. Founded in 2005 in Ofakim, the private firm operates with 1–10 employees and is part of the OHV Ventures portfolio.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersOfakim, Israel
HQ citystring
Ofakim
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Keyword5 values
retinal spectral imaging, ophthalmic diagnostic imaging, vision disease screening, medical imaging systems, retinal disease diagnosis
Industry1 code
PRIMARYHLAHAJAB
Retinal Imaging & OCT Systems (OCT/OCTA, Fundus Cameras, Fluorescein/ICG Angiography)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)
NAICS code1 code
  • Ophthalmic Goods Manufacturing339115
SIC code2 codes
  • Optical Instruments & Lenses3827
  • Laboratory Analytical Instruments3826
Product category
Ophthalmic Diagnostic Imaging
Social media profiles1 record
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Next Dimension (NeD) provides a Retinal Spectral Imaging System. The system is intended for the early diagnosis of vision-threatening diseases.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Retinal Spectral Imaging System
CategoryOphthalmic diagnostic imaging
Description

A retinal spectral imaging system intended for the early diagnosis of vision-threatening diseases.

No data
Peers10 records
TypeEmerging player
Description

Mediwhale develops AI-based retinal imaging diagnostics (Reti-CVD, DrNoon) for systemic disease risk assessment, an emerging peer applying image-based analytics to the same retinal-imaging modality.

TypeEmerging player
Description

Eyenuk develops AI-enabled retinal image analysis (EyeArt) for autonomous detection of diabetic retinopathy, an emerging player applying novel technology (AI/spectral) to the same early-detection mission as NeD.

TypeEmerging player
Description

Digital Diagnostics built IDx-DR, an autonomous AI diagnostic system for diabetic retinopathy, an emerging adjacent competitor operating in the same disease-detection space with a software-only approach.

4Carl Zeiss Meditec
TypeBroad incumbent
Description

Zeiss Meditec offers the Cirrus HD-OCT and a broad portfolio of ophthalmic diagnostic and surgical devices, serving the same retinal imaging customer base as NeD but at vastly greater scale across multiple product lines.

TypeDirect peer
Description

Heidelberg Engineering is a leading manufacturer of retinal diagnostic imaging systems (Spectralis OCT/OCTA, HRT), making it the closest direct competitor to a Retinal Spectral Imaging System targeting the same ophthalmic specialists and indications.

TypeDirect peer
Description

Optos produces ultra-widefield retinal imaging devices used for early detection of retinal disease, closely comparable to NeD's stated focus on early diagnosis of vision-threatening disease.

TypeBroad incumbent
Description

Topcon's 3D-OCT and Maestro systems are widely deployed retinal imaging products used by ophthalmologists and optometrists, overlapping directly with NeD's customer use case while operating across a much broader eyecare portfolio.

TypeDirect peer
Description

CenterVue, now part of iCare, develops fundus and OCT-based retinal imaging systems for screening and diagnosis, making it a directly comparable peer in non-mydriatic and clinical retinal imaging.

TypeBroad incumbent
Description

Nidek manufactures OCT and fundus imaging devices sold into ophthalmology clinics worldwide, making it a comparable hardware vendor serving the same diagnostic imaging workflow that NeD's spectral system targets.

TypeDirect peer
Description

Optovue pioneered OCT angiography (OCTA) and competes directly in spectral-domain and functional retinal imaging, addressing the same clinical workflow of detecting early retinal pathology.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat1 record

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

No data
Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Next Dimension (NeD)

Ophthalmic Diagnostic Imagingohv.co.il

Next Dimension (NeD) is an Israeli medical device company developing Retinal Spectral Imaging Systems for early diagnosis of vision-threatening diseases. Founded in 2005 in Ofakim, the private firm operates with 1–10 employees and is part of the OHV Ventures portfolio.

What Next Dimension (NeD) does

Next Dimension (NeD) is a privately held Israeli medical device company developing Retinal Spectral Imaging Systems intended for the early diagnosis of vision-threatening diseases. The company's core product is a spectral imaging device designed to capture multi-wavelength retinal data to enable earlier detection of ocular pathology compared to conventional fundus imaging. The intended end users are eye care professionals such as ophthalmologists and optometrists operating in clinical settings where early detection of retinal disease drives better patient outcomes.

Founded in 2005 and headquartered in Ofakim, Israel, the company operates with a small team of 1–10 employees as a private for-profit entity. The company is listed as a portfolio company of OHV Ventures, an Israeli venture capital firm, based on the website URL pattern (ohv.co.il/asp/portfolio_company.asp?id=123), indicating institutional backing, though no funding rounds, amounts, or investor details are disclosed in the source material. The company has no publicly disclosed revenue, named customers, distribution partnerships, or pricing model, and no management team composition is available in the source data.

The supporting source material provided is largely about an unrelated Israeli moving services business (MoversTLV / Afterio Ltd.), indicating a data sourcing error. The analysis below is grounded in the firmographic definition provided and is necessarily limited in its conclusions due to the absence of substantive company-specific data such as funding history, clinical validation milestones, regulatory clearances (FDA/CE), customer references, or commercialization metrics.

Next Dimension (NeD) firmographics

Firmographics
Name
Next Dimension (NeD)
Legal name
Afterio Ltd. (אפטריו בעמ)
Website
https://ohv.co.il
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
1–10 employees
Short description
Next Dimension (NeD) is an Israeli medical device company developing Retinal Spectral Imaging Systems for early diagnosis of vision-threatening diseases. Founded in 2005 in Ofakim, the private firm operates with 1–10 employees and is part of the OHV Ventures portfolio.
Ownership category
akta.pro rank

Next Dimension (NeD) industry classification

Industry
Product category
Ophthalmic Diagnostic Imaging
NAICS
Ophthalmic Goods Manufacturing (339115)
SIC
Optical Instruments & Lenses (3827), Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAHAJAB
Retinal Imaging & OCT Systems (OCT/OCTA, Fundus Cameras, Fluorescein/ICG Angiography)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)

Keywords

  • Retinal spectral imaging
  • Ophthalmic diagnostic imaging
  • Vision disease screening
  • Medical imaging systems
  • Retinal disease diagnosis

Where Next Dimension (NeD) is headquartered

Location

Headquarters

HQ city
Ofakim
HQ country
Israel
HQ region
Middle East

Markets served

Next Dimension (NeD) business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing

Next Dimension (NeD) product offering

Product offering

Core offering

Next Dimension (NeD) provides a Retinal Spectral Imaging System. The system is intended for the early diagnosis of vision-threatening diseases.

Differentiator

Problem solved

Functional benefit

Products and services

  • Retinal Spectral Imaging System A retinal spectral imaging system intended for the early diagnosis of vision-threatening diseases.

Next Dimension (NeD) technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Next Dimension (NeD) competitors and assessment

Company assessment

Emerging players

  • Mediwhale: Mediwhale develops AI-based retinal imaging diagnostics (Reti-CVD, DrNoon) for systemic disease risk assessment, an emerging peer applying image-based analytics to the same retinal-imaging modality.
  • Eyenuk: Eyenuk develops AI-enabled retinal image analysis (EyeArt) for autonomous detection of diabetic retinopathy, an emerging player applying novel technology (AI/spectral) to the same early-detection mission as NeD.
  • Digital Diagnostics (IDx-DR): Digital Diagnostics built IDx-DR, an autonomous AI diagnostic system for diabetic retinopathy, an emerging adjacent competitor operating in the same disease-detection space with a software-only approach.

Broad incumbents

  • Carl Zeiss Meditec: Zeiss Meditec offers the Cirrus HD-OCT and a broad portfolio of ophthalmic diagnostic and surgical devices, serving the same retinal imaging customer base as NeD but at vastly greater scale across multiple product lines.
  • Topcon Healthcare: Topcon's 3D-OCT and Maestro systems are widely deployed retinal imaging products used by ophthalmologists and optometrists, overlapping directly with NeD's customer use case while operating across a much broader eyecare portfolio.
  • Nidek: Nidek manufactures OCT and fundus imaging devices sold into ophthalmology clinics worldwide, making it a comparable hardware vendor serving the same diagnostic imaging workflow that NeD's spectral system targets.

Direct peers

  • Heidelberg Engineering: Heidelberg Engineering is a leading manufacturer of retinal diagnostic imaging systems (Spectralis OCT/OCTA, HRT), making it the closest direct competitor to a Retinal Spectral Imaging System targeting the same ophthalmic specialists and indications.
  • Optos (Nikon): Optos produces ultra-widefield retinal imaging devices used for early detection of retinal disease, closely comparable to NeD's stated focus on early diagnosis of vision-threatening disease.
  • CenterVue (iCare): CenterVue, now part of iCare, develops fundus and OCT-based retinal imaging systems for screening and diagnosis, making it a directly comparable peer in non-mydriatic and clinical retinal imaging.
  • Optovue (Visionix / BioMérieux): Optovue pioneered OCT angiography (OCTA) and competes directly in spectral-domain and functional retinal imaging, addressing the same clinical workflow of detecting early retinal pathology.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat1 record

Key risks4 records

Key highlights4 records

Customer concentration

Next Dimension (NeD) social profiles

Digital presence

Next Dimension (NeD) financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Next Dimension (NeD) leadership team

Management profile

Number of profiles

Next Dimension (NeD) funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Next Dimension (NeD) M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Next Dimension (NeD)

What does Next Dimension (NeD) do?

Next Dimension (NeD) provides a Retinal Spectral Imaging System. The system is intended for the early diagnosis of vision-threatening diseases.

Is Next Dimension (NeD) a public or private company?

Next Dimension (NeD) is a private company. It is classified as unknown and is currently operating.

When was Next Dimension (NeD) founded?

Next Dimension (NeD) was founded in 2005. It employs 1 to 10 people.

Where is Next Dimension (NeD) based?

Next Dimension (NeD) is headquartered in Ofakim, Israel, in the Middle East region.

Who are Next Dimension (NeD)'s main competitors?

Emerging players on record are Mediwhale, Eyenuk and Digital Diagnostics (IDx-DR). Broad incumbents are Carl Zeiss Meditec, Topcon Healthcare and Nidek. Direct peers are Heidelberg Engineering, Optos (Nikon), CenterVue (iCare) and Optovue (Visionix / BioMérieux).

Does Next Dimension (NeD) have an API?

No public API is recorded for Next Dimension (NeD).

What industry is Next Dimension (NeD) in?

Next Dimension (NeD)'s product category is Ophthalmic Diagnostic Imaging. Its primary akta.pro industry code is HLAHAJAB, Retinal Imaging & OCT Systems (OCT/OCTA, Fundus Cameras, Fluorescein/ICG Angiography). Its NAICS code is 339115 and its SIC code is 3827.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales